Precision Medicine and the Role of Genetic Mutations on Comorbid Conditions Unveiled
November 17, 2021 | Chapter Event
Have you ever wondered why medical treatments worked in some patient populations and not others?
Join the HIMSS Northern California chapter on November 17, 2021 at 10:00am - 11:00am PST to discuss what precision medicine means for you and how it changes our understanding and treatment of disease states.
Many factors such as environmental factors, genetic factors, lifestyle choices, and our human biome affect which diseases we acquire and how they progress. With healthcare systems taking on risks to improve outcomes, they pay attention to each patient’s situation to improve outcomes and lower the risk of therapy failures. We have learned that a “one size fits all” approach is inadequate for results. New therapies and drug discoveries require years of genetic testing before they can be approved.
The impact of genetics on specific conditions and the way genetic mutations occur drive comorbid occurrence. This event will explore the areas within precision medicine that bring new drug discovery and how new computational methods such as quantum computing are applied to this area.
Speakers
- David Rhew, MD, Global Chief Medical Officer & VP of Healthcare, Microsoft
- Cecil Lynch, MD, MS, Global Biobedical Informatics Lead, Accenture
- Clem McDonald, MD, Senior Investigator, Office of the Director, National Library of Medicine
Sponsored content. The views and opinions expressed in this content or by commenters are those of the author and do not necessarily reflect the official policy or position of HIMSS or its affiliates.
